FilingPulse

FBRX insider transaction filings

Forte Biosciences, Inc. — 31 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-06. Screen FBRX transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-064Wagner Paul A. — SEE REMARKS, DirectorOption exercise (M): 1,250 · Tax withholding (F): 98 @ $21.32 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2026-07-064Riley Antony A — CHIEF FINANCIAL OFFICEROption exercise (M): 375 · Tax withholding (F): 134 @ $21.32 · Option exercise (M): 375 (derivative) @ $0EDGAR
2026-06-174Wagner Paul A. — SEE REMARKS, DirectorGrant/award (A): 500,000 (derivative) @ $0EDGAR
2026-06-174Riley Antony A — CHIEF FINANCIAL OFFICERGrant/award (A): 22,000 (derivative) @ $0EDGAR
2026-06-024Kapoor Shivpreet Singh — DirectorGrant/award (A): 18,353 (derivative) @ $0EDGAR
2026-06-024Brun Scott C. — DirectorGrant/award (A): 18,353 (derivative) @ $0EDGAR
2026-06-024Kornfeld Steven — DirectorGrant/award (A): 18,353 (derivative) @ $0EDGAR
2026-06-024Doberstein Stephen K — DirectorGrant/award (A): 18,353 (derivative) @ $0EDGAR
2026-06-024VINCENT RICHARD G — DirectorGrant/award (A): 18,353 (derivative) @ $0EDGAR
2026-06-024GRYSKA DAVID W — DirectorGrant/award (A): 18,353 (derivative) @ $0EDGAR
2026-04-034Wagner Paul A. — SEE REMARKS, DirectorOption exercise (M): 1,250 · Tax withholding (F): 98 @ $24.86 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2026-04-034Riley Antony A — CHIEF FINANCIAL OFFICEROption exercise (M): 375 · Tax withholding (F): 134 @ $24.86 · Option exercise (M): 375 (derivative) @ $0EDGAR
2026-01-134Wagner Paul A. — SEE REMARKS, DirectorGrant/award (A): 270,000 (derivative) @ $0 · Grant/award (A): 180,000 (derivative) @ $0EDGAR
2026-01-134Riley Antony A — CHIEF FINANCIAL OFFICERGrant/award (A): 90,000 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2026-01-024Wagner Paul A. — SEE REMARKS, DirectorOption exercise (M): 1,250 @ $0 · Tax withholding (F): 164 @ $27.27 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2026-01-024Riley Antony A — CHIEF FINANCIAL OFFICERPurchase (P): 9,680 @ $26.33 · Option exercise (M): 375 @ $0 · Tax withholding (F): 154 @ $27.27 · Option exercise (M): 375 (derivative) @ $0EDGAR
2025-10-024Wagner Paul A. — SEE REMARKS, DirectorOption exercise (M): 1,250 @ $0 · Tax withholding (F): 98 @ $14.52 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2025-10-024Riley Antony A — CHIEF FINANCIAL OFFICEROption exercise (M): 375 @ $0 · Tax withholding (F): 134 @ $14.52 · Option exercise (M): 375 (derivative) @ $0EDGAR
2025-07-034Wagner Paul A. — SEE REMARKS, DirectorOption exercise (M): 1,250 @ $0 · Tax withholding (F): 98 @ $12.44 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2025-07-034Riley Antony A — CHIEF FINANCIAL OFFICEROption exercise (M): 375 @ $0 · Tax withholding (F): 134 @ $12.44 · Option exercise (M): 375 (derivative) @ $0EDGAR
2025-04-024Wagner Paul A. — SEE REMARKS, DirectorOption exercise (M): 1,250 @ $0 · Tax withholding (F): 18 @ $7.43 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2025-04-024Riley Antony A — CHIEF FINANCIAL OFFICEROption exercise (M): 375 @ $0 · Tax withholding (F): 154 @ $7.43 · Option exercise (M): 375 (derivative) @ $0EDGAR
2025-03-214Kapoor Shivpreet Singh — DirectorGrant/award (A): 31,000 (derivative) @ $0EDGAR
2025-03-214Doberstein Stephen K — DirectorGrant/award (A): 31,000 (derivative) @ $0EDGAR
2025-03-214Brun Scott C. — DirectorGrant/award (A): 31,000 (derivative) @ $0EDGAR
2025-03-214Kornfeld Steven — DirectorGrant/award (A): 31,000 (derivative) @ $0EDGAR
2025-03-214Wagner Paul A. — SEE REMARKS, DirectorGrant/award (A): 920,000 (derivative) @ $0EDGAR
2025-03-214Riley Antony A — CHIEF FINANCIAL OFFICERGrant/award (A): 323,000 (derivative) @ $0EDGAR
2025-03-214VINCENT RICHARD G — DirectorGrant/award (A): 31,000 (derivative) @ $0EDGAR
2025-03-214FINCK BARBARA K — DirectorGrant/award (A): 31,000 (derivative) @ $0EDGAR
2025-03-214GRYSKA DAVID W — DirectorGrant/award (A): 31,000 (derivative) @ $0EDGAR

Recent 8-K events — Forte Biosciences, Inc.

FiledFormItems reportedSource
2026-07-278-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-098-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-04-098-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-04-018-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-11-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-08-148-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-06-258-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-06-238-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=FBRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →